A Wegovyt piacra dob Novo Nordisk idn elszr szmt bevtelcskkensre a termk bevezetse ta, rszben az Eli Lilly ersd versenye miatt
Recombinant DNA technology is the primary method used to manufacture most GLP-1 medicines
If you want more class-level context, Common Diabetes Medications explains how SGLT2 medicines differ from other therapies, and the Type 2 Diabetes Hub gathers related reading in one place
However, there was a statistically significant reduction in the risk of hypoglycemia by about 30% [RR=0.70, 95% CI (0.57, 0.87), p =0.001] ( Figure 4 ), and pneumonia by about 25% [RR=0.85, 95% CI (0.75, 0.97), p =0.01] ( Figure 5 )
Reassurance that the heart rate increase is generally well-tolerated can alleviate anxiety
The logic is simple: faster escalation means less time at sub-therapeutic doses and earlier onset of meaningful weight loss